Cann Group Ltd. ( (AU:CAN) ) has issued an announcement.
Cann Group Limited has lodged a cleansing prospectus with ASIC and ASX for the issuance of convertible notes, options, and placement shares, following a recent drawdown of convertible securities. The primary aim is to remove on-sale restrictions related to the proposed securities issuance, potentially impacting the company’s financial flexibility and market operations.
More about Cann Group Ltd.
Cann Group Limited is a company focused on enhancing patients’ lives by developing, producing, and supplying innovative cannabis medicines. With research facilities and corporate headquarters in Melbourne, the company operates a large-scale cultivation and GMP manufacturing facility near Mildura, Victoria. Cann Group offers a range of dried flower and oil products, active pharmaceutical ingredients, and extracts to customers in Australia and globally. It also owns Satipharm and its patent-protected capsule technology.
YTD Price Performance: 70.0%
Average Trading Volume: 1,000
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $8.22M
For an in-depth examination of CAN stock, go to TipRanks’ Stock Analysis page.